InvestorWire NewsRoom

Press Release

Fortress Biotech, Inc. (NASDAQ: FBIO) Featured in Virtual Coverage of the 34th Annual Roth Conference
March 17, 2022

Fortress Biotech, Inc. (NASDAQ: FBIO) Featured in Virtual Coverage of the 34th Annual Roth Conference

Fortress Biotech, Inc. (NASDAQ: FBIO) is engaged in the acquisition, development and commercialization of high-potential marketed and development-stage drugs and drug candidates in six large-market areas, including oncology, rare diseases and gene therapy. The innovative biopharmaceutical company currently has nine marketed prescription pharmaceutical products and more than thirty programs in development at Fortress, at its majority-owned and majority-controlled partners and at partners it founded and in which it holds significant minority ownership positions.

The company has established partnerships with some of the world’s leading academic research institutions and biopharmaceutical companies to maximize each opportunity to its full potential, including AstraZeneca plc, City of Hope, Fred Hutchinson Cancer Research Center, St. Jude Children’s Research Hospital, Nationwide Children’s Hospital and Sentynl Therapeutics, Inc. Driven by a world-class business development team that is focused on further expanding the company’s portfolio of product opportunities, Fortress is advancing its diversified pipeline through a streamlined operating structure that fosters efficient drug development

To view the recorded fireside chat, visit https://www.fortressbiotech.com/news-media/events

To view IBN’s virtual coverage of Roth’s 34th Annual Conference, visit https://ibn.fm/Roth2022

About InvestorBrandNetwork’s Virtual Coverage

The InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company, is providing the online investment community with a custom-built portal that includes summaries on each of the publicly traded companies participating virtually at Roth’s 34th Annual Conference. In addition to enabling proficient evaluation of each company via one-click access to market research tools and helpful website links, IBN is using social media and syndicated articles to maximize the visibility of the event.

For more than a decade, IBN has provided real-time coverage for numerous global events and conferences through its various brands, social media accounts and investment newsletters. To further expand visibility of participating companies at these events, and to ensure another successful year for its event collaborations, IBN’s syndication partners have extended digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(862) 930-1404

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up InvestorNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).